1 607

Cited 1 times in

High-dose versus low-dose losartan in patients with heart failure

DC Field Value Language
dc.contributor.author강석민-
dc.contributor.author오재원-
dc.date.accessioned2015-04-23T16:41:18Z-
dc.date.available2015-04-23T16:41:18Z-
dc.date.issued2010-
dc.identifier.issn0140-6736-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/101038-
dc.description.statementOfResponsibilityopen-
dc.relation.isPartOfLANCET-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.subject.MESHAngiotensin II Type 1 Receptor Blockers/administration & dosage*-
dc.subject.MESHAngiotensin II Type 1 Receptor Blockers/adverse effects-
dc.subject.MESHHeart Failure/drug therapy*-
dc.subject.MESHHumans-
dc.subject.MESHLosartan/administration & dosage*-
dc.subject.MESHLosartan/adverse effects-
dc.subject.MESHUric Acid/blood-
dc.titleHigh-dose versus low-dose losartan in patients with heart failure-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학)-
dc.contributor.googleauthorSeok-Min Kang-
dc.contributor.googleauthorJaewon Oh-
dc.contributor.googleauthorNamki Hong-
dc.identifier.doi10.1016/S0140-6736(10)60473-4-
dc.admin.authorfalse-
dc.admin.mappingfalse-
dc.contributor.localIdA00037-
dc.contributor.localIdA02395-
dc.relation.journalcodeJ02152-
dc.identifier.eissn1474-547X-
dc.identifier.pmid20346808-
dc.identifier.urlhttp://www.sciencedirect.com/science/article/pii/S0140673610604734-
dc.contributor.alternativeNameKang, Seok Min-
dc.contributor.alternativeNameOh, Jae Won-
dc.contributor.affiliatedAuthorKang, Seok Min-
dc.contributor.affiliatedAuthorOh, Jae Won-
dc.citation.volume375-
dc.citation.number9720-
dc.citation.startPage1079-
dc.identifier.bibliographicCitationLANCET, Vol.375(9720) : 1079, 2010-
dc.identifier.rimsid54528-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.